
Colorectal Surgeon | Surgical Scientist | Innovator @asu @honorhealth @mayoclinic #colorectalresearch #colorectalsurgery
Phoenix, AZ
Joined October 2013
- Tweets18.6K
- Following2.5K
- Followers7K
- Likes12.8K
Debby Keller, MD retweeted
Exciting news from #DCRJournalClub and Discussion Forums!
Join the discussion without the hassle of re-registering for each meeting by signing up for our newsletter. Sign up to receive emails with a direct Zoom link
to upcoming sessions!
bit.ly/4vY2LV1
Debby Keller, MD retweeted
This is fantastic news. Looking forward to more interactive sessions with POLLs and more questions from the audience. We are starting back on July 27. @DCREdInChief, @FicheraAlessand, @debby_keller
Exciting news from #DCRJournalClub and Discussion Forums!
Join the discussion without the hassle of re-registering for each meeting by signing up for our newsletter. Sign up to receive emails with a direct Zoom link
to upcoming sessions!
bit.ly/4vY2LV1
Debby Keller, MD retweeted
Replying to @debby_keller
@debby_keller describes emerging cancer probes and applications in practice @isfgs @MedStarGUH @MedStarHealth @Georgetown
Debby Keller, MD retweeted
🔪🤖Incorporating robotic ESD into your practice? Learn some tips from this challenging lesion at 24cm. Check out our #CoDiMovieNights 🤖🔪
Full link: tinyurl.com/vwptb329
@ZGaroufalia @debby_keller @RyanPreece2 @stevebrownsheff @LeandroSiragusa @EmreGorgunMD @MetinErkayaMD
Debby Keller, MD retweeted
🔊Surgery impact factor increases to 3.2‼️
We owe this achievement to YOU our readers, authors and reviewers👏🏻
We also acknowledge all the hard work that our editorial and publishing teams put in all year round🗓️
We look forward to continuing this exciting journey with you🙏🏻
Debby Keller, MD retweeted
Thank you to our @SurgJournal editors, editorial board members, reviewers, authors, and readers for our 0.5 increased impact factor @juliomayol @RaulRosenthalMD @debby_keller @A160186 @nlavellaneda @luciacolorectal @PipeCabreraV @pferrada1 @DeliaCortesGuir @ManishChandSurg
Debby Keller, MD retweeted
It's Showtime! Two interventions reduce operating room turnover time by 20% in an academic medical center
#OpenAccess 🔓
surgjournal.com/article/S003…
@SWexner @CaitlinWHicks @juliomayol @SyedAAhmad5 @debby_keller @TomVargheseJr @DrHasanAlam @luciacolorectal
#SoMe4Surgery
Debby Keller, MD retweeted
🤖📷Tackling lateral pelvic nodes? Check out our #CoDiMovieNights to see an implementation of the Hugo™ RAS platform 📷🤖
Full link: tinyurl.com/4mfcd85c
@ZGaroufalia @debby_keller @RyanPreece2 @stevebrownsheff @LeandroSiragusa @ACPGBI_EduTrain @YouESCP
Debby Keller, MD retweeted
Earlier today…
Our residents selecting papers from @SurgJournal for discussion during our critical appraisal sessions.
No form of coercion was employed; residents selected studies willingly & independently☺️
#SoMe4Surgery
@SWexner @CaitlinWHicks @juliomayol @SyedAAhmad5
Debby Keller, MD retweeted
🔪🧲Do you struggle with access to surgical assistants? Check out our #CoDiMovieNights to see how magnetic lap tools can help 🧲🔪
Full link: tinyurl.com/2d433xv5
@ZGaroufalia @debby_keller @RyanPreece2 @stevebrownsheff @LeandroSiragusa @ACPGBI_EduTrain @YouESCP
Debby Keller, MD retweeted
Integrating geriatric expertise into multidisciplinary tumour boards for older adults with colorectal cancer: a pragmatic real-world cohort study geriatriconcology.net/articl… @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier #ComprehensiveGeriatricAssessment #Frailty
Debby Keller, MD retweeted
Training the next generation of surgical editors: Launching the surgery junior editorial board
surgjournal.com/article/S003…
@SWexner @CaitlinWHicks @juliomayol @SyedAAhmad5 @debby_keller @TomVargheseJr @A160186 @luciacolorectal @PipeCabreraV @surgnags @nlavellaneda
#SoMe4Surgery
Debby Keller, MD retweeted
In patients undergoing permanent colostomy for #RectalCancer, use of a funnel-shaped intra-abdominal mesh reduced parastomal hernia incidence and size at 3 years without increased complications compared with no mesh. ja.ma/4cqspLd
Debby Keller, MD retweeted
🔪📷Would you consider a transvaginal approach for a recurrent pelvic tumour? Check out our #CoDiMovieNights to learn more 📷🔪
Full video link: tinyurl.com/ynck2bxy
@ZGaroufalia @debby_keller @RyanPreece2 @stevebrownsheff @LeandroSiragusa @ACPGBI_EduTrain @YouESCP
Debby Keller, MD retweeted
Delayed diagnosis of anastomotic leak after #ColonResection was associated with increased mortality, more complications, and longer hospital stay, highlighting the importance of early detection and intervention.
ja.ma/3OnBlYl
Debby Keller, MD retweeted
Debby Keller, MD retweeted
💡The fascinating part is how a drug
(💉◼️Leronlimab)
in latter phases of development for treatment of HIV🦠is helping T-cells fight cancer 🦀.
Specially focusing on pMMR/MSS “cold” 🧊 #ColorectalCancer.
#AACR26 @AACR
◼️CLOVER☘️Trial link:
🔗 clinicaltrials.gov/study/NCT…
Debby Keller, MD retweeted
#AACR26 Looking forward to unveiling the first set of results on the👇🏽phase-2 study!
We call it the CLOVER☘️Trial.
CCR5-targeting
Leronlimab with
Oral chemotherapy &
VEGF-inhibitor
Enriched
Regimen
💡Building upon options for our patients with #ColorectalCancer.
@OncoAlert
Debby Keller, MD retweeted
Locoregional and systemic control after total neoadjuvant therapy with short-course radiotherapy for locally advanced rectal cancer: long-term outcomes from the LARCT-US study
➡️ doi.org/10.1093/bjs/znag014
TNT with short-course radiotherapy (5×5 Gy) followed by CAPOX/FOLFOX achieved excellent local and distant control in advanced rectal cancer, possibly driven by optimized surgical margins
Work by Israa Imam , Per J Nilsson , Tanweera Khan , Eva Angenete , Bengt Glimelius
#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @evanscolorectal @robhinchliffe1 @bplwijn @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol @ksoreide #colorectalsurgery #StepUp4CRC @FightCRC @ACPGBI #ERAS @dice_europe #Crohn #proctology @Dukes_Club @ACPGBI_EduTrain @AECP_FAECP @PelvExGroup @escp_tweets @YouESCP #TeachMeColoproctology
#Some4COLoprocto
Debby Keller, MD retweeted
New results provide estimates for average ctDNA detectable sojourn time in tumors across multiple cancer sites and stages and can inform the design of future screening studies for multicancer early detection.
acsjournals.onlinelibrary.wi…
@OncoAlert #MCED #MCD #CancerDetection































